- Home
- AUPH vs AVPT Comparison
AUPH vs AVPT Comparison
Compare AUPH & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | AVPT |
|---|---|---|
| Founded | 1993 | 2001 |
| Country | Canada | United States |
| Employees | N/A | 3443 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUPH | AVPT |
|---|---|---|
| Price | $15.31 | $11.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $17.25 | $16.64 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | $25.00 |
| Revenue Next Year | $15.74 | $19.63 |
| P/E Ratio | ★ $60.78 | $1,348.94 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $7.29 | $8.84 |
| 52 Week High | $16.88 | $19.95 |
Technical Indicators
Market Signals| Indicator | AUPH | AVPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 65.33 |
| Support Level | $14.53 | $9.24 |
| Resistance Level | $16.32 | $14.33 |
| Average True Range (ATR) | 0.50 | 0.44 |
| MACD | -0.06 | 0.10 |
| Stochastic Oscillator | 27.98 | 91.41 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About AVPT AvePoint Inc.
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.